Aura Biosciences (AURA) Competitors $5.89 -0.05 (-0.84%) Closing price 04:00 PM EasternExtended Trading$5.94 +0.05 (+0.85%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AURA vs. AMPH, ETNB, AUPH, GYRE, MLYS, WVE, PAHC, ARDX, COLL, and NTLAShould you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Amphastar Pharmaceuticals (AMPH), 89bio (ETNB), Aurinia Pharmaceuticals (AUPH), Gyre Therapeutics (GYRE), Mineralys Therapeutics (MLYS), Wave Life Sciences (WVE), Phibro Animal Health (PAHC), Ardelyx (ARDX), Collegium Pharmaceutical (COLL), and Intellia Therapeutics (NTLA). These companies are all part of the "pharmaceutical products" industry. Aura Biosciences vs. Amphastar Pharmaceuticals 89bio Aurinia Pharmaceuticals Gyre Therapeutics Mineralys Therapeutics Wave Life Sciences Phibro Animal Health Ardelyx Collegium Pharmaceutical Intellia Therapeutics Amphastar Pharmaceuticals (NASDAQ:AMPH) and Aura Biosciences (NASDAQ:AURA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation. Do institutionals and insiders believe in AMPH or AURA? 65.1% of Amphastar Pharmaceuticals shares are held by institutional investors. Comparatively, 96.8% of Aura Biosciences shares are held by institutional investors. 27.5% of Amphastar Pharmaceuticals shares are held by insiders. Comparatively, 5.4% of Aura Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has better valuation and earnings, AMPH or AURA? Amphastar Pharmaceuticals has higher revenue and earnings than Aura Biosciences. Aura Biosciences is trading at a lower price-to-earnings ratio than Amphastar Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmphastar Pharmaceuticals$730.66M1.59$137.54M$2.768.85Aura BiosciencesN/AN/A-$76.41M-$1.90-3.11 Do analysts rate AMPH or AURA? Amphastar Pharmaceuticals currently has a consensus target price of $32.33, suggesting a potential upside of 32.39%. Aura Biosciences has a consensus target price of $22.75, suggesting a potential upside of 284.62%. Given Aura Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Aura Biosciences is more favorable than Amphastar Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amphastar Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Aura Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Which has more risk and volatility, AMPH or AURA? Amphastar Pharmaceuticals has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Aura Biosciences has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Does the media favor AMPH or AURA? In the previous week, Aura Biosciences had 3 more articles in the media than Amphastar Pharmaceuticals. MarketBeat recorded 7 mentions for Aura Biosciences and 4 mentions for Amphastar Pharmaceuticals. Amphastar Pharmaceuticals' average media sentiment score of 1.48 beat Aura Biosciences' score of 0.53 indicating that Amphastar Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amphastar Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aura Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is AMPH or AURA more profitable? Amphastar Pharmaceuticals has a net margin of 21.80% compared to Aura Biosciences' net margin of 0.00%. Amphastar Pharmaceuticals' return on equity of 26.44% beat Aura Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Amphastar Pharmaceuticals21.80% 26.44% 11.89% Aura Biosciences N/A -41.57%-36.43% Does the MarketBeat Community prefer AMPH or AURA? Amphastar Pharmaceuticals received 366 more outperform votes than Aura Biosciences when rated by MarketBeat users. Likewise, 65.83% of users gave Amphastar Pharmaceuticals an outperform vote while only 62.79% of users gave Aura Biosciences an outperform vote. CompanyUnderperformOutperformAmphastar PharmaceuticalsOutperform Votes39365.83% Underperform Votes20434.17% Aura BiosciencesOutperform Votes2762.79% Underperform Votes1637.21% SummaryAmphastar Pharmaceuticals beats Aura Biosciences on 12 of the 18 factors compared between the two stocks. Get Aura Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AURA vs. The Competition Export to ExcelMetricAura BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$297.59M$2.92B$5.33B$8.34BDividend YieldN/A1.63%5.20%4.10%P/E Ratio-3.4231.0326.7619.63Price / SalesN/A392.08394.80118.85Price / CashN/A168.6838.3234.62Price / Book1.293.216.744.49Net Income-$76.41M-$72.35M$3.23B$248.23M7 Day Performance-0.59%1.41%0.10%-0.97%1 Month Performance2.69%1.44%8.81%10.82%1 Year Performance-19.41%-25.74%18.52%9.12% Aura Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AURAAura Biosciences2.8314 of 5 stars$5.89-0.8%$22.75+286.2%-17.0%$296.08MN/A-3.4050Positive NewsAnalyst ForecastInsider TradeGap DownAMPHAmphastar Pharmaceuticals4.2325 of 5 stars$24.79-0.3%$32.33+30.4%-44.3%$1.18B$730.66M8.261,620ETNB89bio2.7399 of 5 stars$7.70-1.0%$26.43+243.2%+8.1%$1.12BN/A-2.6540Positive NewsGap UpAUPHAurinia Pharmaceuticals2.4468 of 5 stars$8.07-1.5%$11.50+42.5%+49.5%$1.09B$247.30M-53.80300GYREGyre Therapeutics0.3817 of 5 stars$11.11-2.1%N/A-17.2%$1.04B$100.64M555.5040News CoverageGap DownTrading HaltedMLYSMineralys Therapeutics2.9125 of 5 stars$15.32-0.2%$38.00+148.0%+30.4%$998.48MN/A-4.2128Analyst UpgradeWVEWave Life Sciences4.3607 of 5 stars$6.46+2.1%$21.17+227.7%-5.4%$995.71M$104.94M-5.82240Positive NewsGap DownPAHCPhibro Animal Health3.4767 of 5 stars$24.13+0.5%$20.00-17.1%+25.0%$978.09M$1.19B50.271,860News CoveragePositive NewsAnalyst RevisionARDXArdelyx4.3927 of 5 stars$4.06+4.6%$10.39+155.9%-49.4%$971.38M$361.71M-25.3890Insider TradeGap DownCOLLCollegium Pharmaceutical4.023 of 5 stars$29.83-1.3%$43.80+46.8%-15.7%$958.50M$664.28M12.86210Positive NewsNTLAIntellia Therapeutics4.6199 of 5 stars$9.06+6.6%$36.90+307.3%-63.6%$938.46M$45.57M-1.67600Analyst ForecastHigh Trading Volume Related Companies and Tools Related Companies Amphastar Pharmaceuticals Competitors 89bio Competitors Aurinia Pharmaceuticals Competitors Gyre Therapeutics Competitors Mineralys Therapeutics Competitors Wave Life Sciences Competitors Phibro Animal Health Competitors Ardelyx Competitors Collegium Pharmaceutical Competitors Intellia Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AURA) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aura Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AURA Stock Free AURA Stock Alerts